Services

1. Pharmaceutical Contract Manufacturing And Packaging: Creams, Lotions And Gels 5/22/2012

   Aphena Health & Beauty has the ability to blend a wide range of viscosities from aqueous based to crèmes, lotions, liquids, gels and powders. 

2. ADME 6/21/2011
   SGS’ Life Science Services provides an extensive pharmacokinetic (PK) and pharmacodynamic (PD) support in pre-clinical and Phase I-III clinical studies in accordance with international regulatory standards (FDA, EMEA, ICH).
3. Aseptic Fill Finish 4/16/2026

   One of the few CDMOs offering sterile fill, device manufacturing, and final assembly at one site — combining expertise, scale, and flexibility for clinical, commercial, and niche production.

4. Pharmaceutical Development 4/24/2023

   Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

5. cGMP Aseptic Manufacturing And Sterile Fill-Finish 1/28/2022

   Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.

6. Formulations For Poorly Soluble And Low Bioavailability Drugs 1/28/2022

   Ascendia specializes in the development of market suitable formulations for poorly water soluble drug substances. Based on the pre-formulation data package and the delivery requirements for the product, we recommend a comprehensive formulation development strategy. We understand that each formulation is unique and must address the specific challenges associated with poor solubility, inadequate bioavailability, and/or unacceptable physical/chemical stability. We also understand the urgency companies have for progressing their pipeline, and our approach maximizes the probability of success by exploring multiple formulation options in parallel if necessary.

7. Clinical Manufacturing In Viral Vaccines 4/14/2014

   Charles River offers more than 20 years of experience in manufacturing viral vaccines.

8. Fill & Finish / Late-Phase And Commercial Pharmaceutical Manufacturing 1/28/2014

   OsoBio is committed to serving as your contract manufacturing organization (CMO) of choice for late-phase clinical trials and bringing them to commercialization – especially those that involve biologic, highly potent or controlled compounds.

9. Lyophilization / Late-Phase And Commercial Pharmaceutical Manufacturing 1/28/2014

   OsoBio is committed to serving as your contract manufacturing organization (CMO) of choice for late-phase clinical trials and bringing them to commercialization – especially those that involve biologic, highly potent or controlled compounds.

10. Fill & Finish / Potent And Cytotoxic Compounds 1/28/2014

    As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.